Tuberculosis control in China: use of modelling to develop targets and policies.

PubWeight™: 0.94‹?›

🔗 View Article (PMC 4622160)

Published in Bull World Health Organ on September 15, 2015

Authors

Hsien-Ho Lin1, Lixia Wang2, Hui Zhang2, Yunzhou Ruan2, Daniel P Chin3, Christopher Dye4

Author Affiliations

1: Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Rm706, No.17 Xuzhou Rd, Taipei 100, Taiwan, China .
2: Chinese Center for Disease Control and Prevention, Beijing, China .
3: China Office, Bill & Melinda Gates Foundation, Beijing, China .
4: Office of the Director General, World Health Organization, Geneva, Switzerland .

Articles cited by this

Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med (2010) 32.89

Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy. Lancet (1998) 6.94

14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial. Lancet (2012) 6.70

National survey of drug-resistant tuberculosis in China. N Engl J Med (2012) 6.28

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev (2013) 5.78

Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis. Am J Respir Crit Care Med (2010) 5.01

Tuberculosis prevalence in China, 1990-2010; a longitudinal analysis of national survey data. Lancet (2014) 3.83

Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci U S A (2009) 2.78

Bayesian melding for estimating uncertainty in national HIV prevalence estimates. Sex Transm Infect (2008) 2.67

Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLoS Med (2012) 2.54

Prospects for tuberculosis elimination. Annu Rev Public Health (2012) 2.50

Targets for global tuberculosis control. Int J Tuberc Lung Dis (2006) 2.16

Mobile direct observation treatment for tuberculosis patients: a technical feasibility pilot using mobile phones in Nairobi, Kenya. Am J Prev Med (2010) 2.15

The benefits to communities and individuals of screening for active tuberculosis disease: a systematic review. Int J Tuberc Lung Dis (2013) 1.96

What lessons can be drawn from tuberculosis (TB) control in China in the 1990s? An analysis from a health system perspective. Health Policy (2005) 1.85

Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review. BMC Infect Dis (2013) 1.57

The impact of new tuberculosis diagnostics on transmission: why context matters. Bull World Health Organ (2012) 1.27

China tuberculosis policy at crucial crossroads: comparing the practice of different hospital and tuberculosis control collaboration models using survey data. PLoS One (2014) 1.14